Form 4: ResMed Executive Ghoshal Sells Shares to Cover Tax Obligations

ResMed's Chief Commercial Officer, Kaushik Ghoshal, disposed of shares to cover tax obligations related to vesting of restricted stock units.

Summary

• Kaushik Ghoshal, Chief Commercial Officer of SaaS at ResMed, sold a total of 2,466.588 shares of ResMed common stock on November 11, 2024.
• The sales were executed to cover tax withholding obligations related to the vesting of restricted stock units.
• The shares were sold at a price of $252.38 per share.
• The transactions involved the vesting of restricted stock units granted on November 18, 2021, November 16, 2022, and November 16, 2023.
• Following these transactions, Mr. Ghoshal directly owns 11,142 shares and indirectly owns 9,628 shares through the Kaushik Ghoshal and Jayati Ghoshal Family Trust.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of any positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales for tax purposes are a common practice across the industry.
• Many companies use restricted stock units as part of executive compensation packages, leading to similar tax-related sales.
• The sale price of $252.38 is specific to ResMed's stock and would be compared to other sales of ResMed stock at the time.

Stakeholder Impact

• The stock sale has a minimal impact on shareholders as it is a routine transaction for tax purposes.
• The sale does not indicate any change in the executive's confidence in the company.

Key Dates

Keywords

ResMed, Kaushik Ghoshal, stock sale, restricted stock units, tax withholding, insider trading, executive compensation